Search Result "BT474"


Targeting EGFR and HER2 with 211At-Labeled Molecules: Unexpected and Expected Dose-Effect Relations in Cultured Tumor Cells

Journal: Current Radiopharmaceuticals
Volume: 1 Issue: 3 Year: 2008 Page: 225-233
Author(s): J. Carlsson, A. C. Steffen, A. L. Sundberg, M. Vikstrom, A. Orlova, L. Gedda, B. Stenerlow, H. Lundqvist, V. Tolmachev

Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 9 Issue: 3 Year: 2011 Page: 184-190
Author(s): Anatasha Crawford, Rita Nahta

Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition

Journal: Current Cancer Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 168-175
Author(s): G. Zoppoli, E. Moran, D. Soncini, M. Cea, A. Garuti, I. Rocco, G. Cirmena, V. Grillo, L. Bagnasco, G. Icardi, F. Ansaldi, S. Parodi, F. Patrone, A. Ballestrero, A. Nencioni

Dynamic Simulations of Pathways Downstream of ERBB-Family, Including Mutations and Treatments: Concordance with Experimental Results

Journal: Current Cancer Drug Targets
Volume: 10 Issue: 7 Year: 2010 Page: 737-757
Author(s): N. Castagnino, L. Tortolina, A. Balbi, R. Pesenti, R. Montagna, A. Ballestrero, D. Soncini, E. Moran, A. Nencioni, S. Parodi

A Small-molecule Inhibitor, 5-O-Tritylthymidine, Targets FAK and Mdm-2 Interaction, and Blocks Breast and Colon Tumorigenesis in vivo

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 4 Year: 2013 Page: 532-545
Author(s): Vita M. Golubovskaya, Nadia L. Palma, Min Zheng, Baotran Ho, Andrew Magis, David Ostrov, William G. Cance

Research Article

Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 15 Issue: 4 Year: 2020 Page: 329-340
Author(s): Ali Rajabi,Ali Saber,Mahsa Pourmahdi,Ali Emami,Reyhaneh Ravanbakhsh,Amir Khodavirdipour,Mehran Khodaei,Molood Akbarzadeh,Sepehr Abdolahi,Mohammad Ali Hosseinpourfeizi,Reza Safaralizadeh

Research Article

Anticancer Effects of Novel Tetrahydro-Dimethyl-Xanthene-Diones

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 7 Year: 2020 Page: 909-916
Author(s): Alagumuthu Manikandan,Arumugam Sivakumar,Poonam S. Nigam,Ayyakannu A. Napoleon

Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro

Journal: Current Cancer Drug Targets
Volume: 10 Issue: 8 Year: 2010 Page: 922-931
Author(s): N. Geis, S. Zell, R. Rutz, W. Li, T. Giese, S. Mamidi, S. Schultz, M. Kirschfink

Research Article

EGFR Kinase Inhibiting Amino-enones for Breast Cancer; CADD Approach

Journal: Current Computer-Aided Drug Design
Volume: 20 Issue: 0 Year: 2024 Page: 1-10
Author(s):

Review Article

Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models

Journal: Current Medicinal Chemistry
Volume: 25 Issue: 1 Year: 2018 Page: 1976-1998
Author(s): Paula Gonzalez-Alonso,Ion Cristobal,Sandra Zazo,Ester Martin-Aparicio,Cristina Chamizo,Juan Madoz-Gurpide,Ana Rovira,Pilar Eroles,Ana Lluch,Joan Albanell,Federico Rojo

Previous   Next

Go To   Results 1 - 1 of 187

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy